Ms. Natoli, Head of Portfolio and Program Management, brings deep expertise in strategic direction and operational oversight of program advancement. She served most recently as Vice President, Program Management at Imara, in which capacity she provided strategic and operational leadership for Imara’s global programs in sickle cell anemia and beta-thalassemia. Previously, Ms. Natoli served as the Executive Director, Program and Alliance Leadership at Bioverativ, a Sanofi Company; prior to that she held roles at AMAG Pharmaceuticals and FORUM Pharmaceuticals. Ms. Natoli holds an M.S. in natural sciences from the Roswell Park Cancer Institute, a division of State University of New York at Buffalo, and graduated with a B.S. in biology-chemistry and medical technology from Elmira College.